The FDA has, on 25 October 2013, approved Zohydro ER (hydrocodone bitartrate extended-release capsules) from Zogenix, for the management of...
The FDA has approved a new formulation of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, from Zogenix, with BeadTek, for the...
Zogenix, Inc. has announced it has submitted to the FDA a supplemental New Drug Application (sNDA) for a modified formulation...
The FDA Anasthetic and Analgesic Advisory Committee found Zohydro (hydrocodone bitartrate extended-release capsules)from Zogenix, was effective in managing Moderate to...
The FDA has accepted for review the new drug application (NDA) for the oral, extended-release hydrocodone therapy ZohydroER from Zogenix...
Zogenix has submitted an New Drug Application (NDA) to the FDA for Zohydro (hydrocodone bitartrate extended-release capsules) for the treatment...
Zogenix, Inc. announced today that it has entered into a definitive agreement to sell its Zohydro ER (hydrocodone bitartrate) business...
The Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee of the FDA voted...